Diress Gedefaw, Dagne Samuel, Alemnew Birhan, Adane Seteamlak, Addisu Amanuel
College of Health Sciences, Woldia University, Woldia, Ethiopia.
College of Medicine and Health Science, Bahir Dar University, Bahir Dar, Ethiopia.
AIDS Res Treat. 2020 Apr 21;2020:8909232. doi: 10.1155/2020/8909232. eCollection 2020.
BACKGROUND: The World Health Organization currently encourages enhanced adherence counseling for human immunodeficiency virus (HIV) seropositive people with a high viral load count before a treatment switch to the second-line regimen, yet little is known about viral load suppression after the outcome of enhanced adherence counseling. Therefore, this study aimed to assess viral suppression after enhanced adherence counseling sessions and its predictors among high viral load HIV seropositive people. METHODS: Institutional-based retrospective cohort study was conducted among 235 randomly selected HIV seropositive people who were on ART and had a high viral load (>1000 copies/ml) from June 2016 to January 2019. The proportion of viral load suppression after enhanced adherence counseling was determined. Time to completion of counseling sessions and time to second viral load tests were estimated by the Kaplan-Meier curve. Log binomial regression was used to identify predictors of viral re-suppression after enhanced adherence counseling sessions. RESULT: The overall viral load suppression after enhanced adherence counseling was 66.4% (60.0-72.4). The median time to start adherence counseling session after high viral load detected date was 8 weeks (IQR 4-8 weeks), and the median time to complete the counseling session was 13 weeks (IQR 8-25 weeks). The probability of viral load suppression was higher among females (ARR = 1.2, 95% CI: 1.02-1.19) and higher educational status (ARR = 1.7, 95% CI: 1.25-2.16). The probability of viral load suppression was lower among people who had 36-59 months duration on ART (ARR = 0.35, 95% CI: 0.130-0.9491) and people who had > 10,000 baseline viral load count (ARR = 0.44, 95% CI: 0.28-0.71). CONCLUSION: This study showed that viral suppression after enhanced adherence counseling was near to the WHO target (70%) but highlights gaps in time to enrolment into counseling session, timely completion of counseling session, and repeat viral load testing after completing the session.
背景:世界卫生组织目前鼓励在人类免疫缺陷病毒(HIV)血清学阳性且病毒载量高的人群转用二线治疗方案之前,加强依从性咨询,但对于强化依从性咨询后的病毒载量抑制情况知之甚少。因此,本研究旨在评估强化依从性咨询后病毒抑制情况及其在高病毒载量HIV血清学阳性人群中的预测因素。 方法:对2016年6月至2019年1月期间随机选取的235名接受抗逆转录病毒治疗(ART)且病毒载量高(>1000拷贝/毫升)的HIV血清学阳性患者进行基于机构的回顾性队列研究。确定强化依从性咨询后病毒载量抑制的比例。通过Kaplan-Meier曲线估计完成咨询疗程的时间和第二次病毒载量检测的时间。采用对数二项回归分析确定强化依从性咨询后病毒再次抑制的预测因素。 结果:强化依从性咨询后的总体病毒载量抑制率为66.4%(60.0 - 72.4)。在检测到高病毒载量日期后开始依从性咨询疗程的中位时间为8周(四分位间距4 - 8周),完成咨询疗程的中位时间为13周(四分位间距8 - 25周)。女性(风险比=1.2,95%置信区间:1.02 - 1.19)和教育程度较高者(风险比=1.7,95%置信区间:1.25 - 2.16)病毒载量抑制的可能性更高。接受抗逆转录病毒治疗36 - 59个月的患者(风险比=0.35,95%置信区间:0.130 - 0.9491)和基线病毒载量>10000的患者(风险比=0.44,95%置信区间:0.28 - 0.71)病毒载量抑制的可能性较低。 结论:本研究表明,强化依从性咨询后的病毒抑制率接近世界卫生组织的目标(70%),但突出了在进入咨询疗程的时间、及时完成咨询疗程以及完成疗程后重复进行病毒载量检测方面存在的差距。
J Epidemiol Glob Health. 2024-9
Front Public Health. 2025-3-19
Lancet HIV. 2019-2
South Afr J HIV Med. 2016-9-30
Ethiop J Health Sci. 2017-2